These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 19212626

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [TRAIL impacts in growth and apoptosis of human ovarian carcinoma cell line SKOV3].
    Li CM, Peng ZL, Yin RT, Hu M.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):761-4. PubMed ID: 17037746
    [Abstract] [Full Text] [Related]

  • 3. Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumors.
    Spierings DC, de Vries EG, Timens W, Groen HJ, Boezen HM, de Jong S.
    Clin Cancer Res; 2003 Aug 15; 9(9):3397-405. PubMed ID: 12960128
    [Abstract] [Full Text] [Related]

  • 4. [Construction of a eukaryotic vector expressing MASPIN gene and its effect on cell apoptosis in gastric cancer cell line SGC7901].
    Zheng AH, Yi YF, Zhou WW.
    Ai Zheng; 2008 Nov 15; 27(11):1161-5. PubMed ID: 19000446
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis.
    Maduro JH, de Vries EG, Meersma GJ, Hougardy BM, van der Zee AG, de Jong S.
    Int J Radiat Oncol Biol Phys; 2008 Oct 01; 72(2):543-52. PubMed ID: 18793956
    [Abstract] [Full Text] [Related]

  • 7. Expression of TRAIL (TNF-related apoptosis-inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomas.
    Koornstra JJ, Kleibeuker JH, van Geelen CM, Rijcken FE, Hollema H, de Vries EG, de Jong S.
    J Pathol; 2003 Jul 01; 200(3):327-35. PubMed ID: 12845629
    [Abstract] [Full Text] [Related]

  • 8. TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5.
    Zhang Y, Zhang B.
    Mol Cancer Res; 2008 Dec 01; 6(12):1861-71. PubMed ID: 19074831
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
    Zhu X, Zhang K, Wang Q, Chen S, Gou Y, Cui Y, Li Q.
    Zhonghua Zhong Liu Za Zhi; 2015 Jun 01; 37(6):404-11. PubMed ID: 26463141
    [Abstract] [Full Text] [Related]

  • 11. Resistance of T-cell acute lymphoblastic leukemia to tumor necrosis factor--related apoptosis-inducing ligand-mediated apoptosis.
    Akahane K, Inukai T, Zhang X, Hirose K, Kuroda I, Goi K, Honna H, Kagami K, Nakazawa S, Endo K, Kubota T, Yagita H, Koyama-Okazaki T, Sugita K.
    Exp Hematol; 2010 Oct 01; 38(10):885-95. PubMed ID: 20670671
    [Abstract] [Full Text] [Related]

  • 12. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Kim YH, Jung EM, Lee TJ, Kim SH, Choi YH, Park JW, Park JW, Choi KS, Kwon TK.
    Free Radic Biol Med; 2008 Mar 15; 44(6):1055-68. PubMed ID: 18164688
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Study of TRAIL receptors expression on the mononuclear cells from multiple myeloma patients and KM3 cells].
    Li J, Li JH, Luo SK, Zhao Y, Zhang GC, Zheng D, Tong XZ, Peng AH.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Apr 15; 26(4):214-7. PubMed ID: 15949263
    [Abstract] [Full Text] [Related]

  • 15. Synergistic antitumor activity of TRAIL combined with chemotherapeutic agents in A549 cell lines in vitro and in vivo.
    Fan QL, Zou WY, Song LH, Wei W.
    Cancer Chemother Pharmacol; 2005 Feb 15; 55(2):189-96. PubMed ID: 15290100
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. DR5 and DcR2 are expressed in human lumbar intervertebral discs.
    Chen B, Ma B, Yang S, Xing X, Gu R, Hu Y.
    Spine (Phila Pa 1976); 2009 Sep 01; 34(19):E677-81. PubMed ID: 19730199
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The prognostic value of TRAIL and its death receptors in cervical cancer.
    Maduro JH, Noordhuis MG, ten Hoor KA, Pras E, Arts HJ, Eijsink JJ, Hollema H, Mom CH, de Jong S, de Vries EG, de Bock GH, van der Zee AG.
    Int J Radiat Oncol Biol Phys; 2009 Sep 01; 75(1):203-11. PubMed ID: 19695437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.